BioCentury
ARTICLE | Clinical News

Staphylococcus lysin: Phase I ongoing

August 17, 2015 7:00 AM UTC

ContraFect said an independent DSMB recommended continuation of a double-blind, placebo-controlled, U.S. Phase I trial to evaluate single ascending doses of IV CF-301 in healthy volunteers based on a ...